CARVER KYLE (Chief Financial Officer) reported 1 transaction at EVOMMUNE, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 12/11/2025ACC: 0001757072-25-000010
Officer· Chief Financial Officer
Since Nov 2025
-13.29K
Net shares
Net seller
$237.1K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
13.29K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−13.29K
Price / share
$17.84
Trade value
$237.09K
% of position
17.5%
12/9/2025
75.80K→62.51K
Total
Net shares
−13.29K
Net value
-$237.09K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/9/2025 | F · Tax Withholding | −13.29K | $17.84 | $237.09K | 17.5% | 75.80K | 62.51K |
| Total | −13.29K | -$237.09K | ||||||
Derivative Transactions0
No derivative transactions reported